Document Detail

Polyglycerol Fatty Acid Ester Surfactant Based Microemulsions for Targeted Delivery of Ceramide AP into the Stratum Corneum: Formulation, Characterisation, In Vitro Release and Penetration Investigation.
MedLine Citation:
PMID:  22691416     Owner:  NLM     Status:  Publisher    
Ceramide AP (CER [AP]) is an integral component of the stratum corneum (SC) lipid matrix and is capable of forming tough and super stable lamellae. It may help to restore the barrier function in aged and affected skin. However, its effectiveness from conventional dosage forms is limited due to its poor solubility and penetration into the SC. Therefore, stable polyglycerol fatty acid ester surfactant (SAA) based CER [AP] microemulsions (MEs) were formulated and characterised to enhance its solubilisation and penetration into the SC. TEGO(®) CARE PL 4 (TCPL4: polyglycerol-4-laurate), isopropyl palmitate (IPP) and water-1, 2 pentandiol (PeG) were used as amphiphilic, oily and hydrophilic components, respectively. The effects of HYDRIOL(®) PGMO.4 (HPGMO4: polyglyceryl-4-oleate) as a co-surfactant (co-SAA) and linoleic acid (Lin A) as part of the oil component on the stability and characteristics of the MEs was investigated. EPR results were used for the first time to reveal MEs nanostructures. The release and penetration behaviour of the MEs was assessed in vitro by using a multi-layer membrane model. The results obtained showed that HPGMO4 and Lin A increased stability and expanded the ME region considerably. The formulations were stable for 10 to >24 months. Dynamic light scattering (DLS) results showed that the droplets were bigger and asymmetric, which might be helpful to localise the CER into the upper layers of the epidermis. Release and penetration from the MEs was superior as compared to the hydrophilic cream (DAB). The rate and extent of CER [AP] released and penetrated from O/W MEs was better than W/O MEs.
Fitsum F Sahle; Hendrik Metz; Johannes Wohlrab; Reinhard H H Neubert
Related Documents :
8799296 - 3-, 6- and 7-hydroxyoctanoic acids are metabolites of medium-chain triglycerides and ex...
15110096 - Excretion of metabolites in urine and faeces from rats dosed with the heterocyclic amin...
12351156 - Metabolites of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (phip) in human urine af...
126826 - Accumulation of 3-hydroxyisobutyric acid, 2-methyl-3-hydroxybutyric acid and 3-hydroxyi...
20605706 - Simultaneous determination of ascorbic acid, epinephrine, and uric acid by differential...
23457116 - Electricity storage in biofuels: selective electrocatalytic reduction of levulinic acid...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-9
Journal Detail:
Title:  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V     Volume:  -     ISSN:  1873-3441     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9109778     Medline TA:  Eur J Pharm Biopharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier B.V. All rights reserved.
Department of Pharmaceutical Technology and Biopharmaceutics, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Wolfgang-Langenbeck Str. 4, D-06120 Halle (Saale), Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Controlled Pitch-Adjustment of Impeller Blades for an Intravascular Blood Pump.
Next Document:  Biodegradable Polymersomes with an Ionizable Membrane: Facile Preparation, Superior Protein Loading ...